Antibody News and Research

RSS

An antibody is a blood protein that is produced in response to and counteracts an antigen. Antibodies are produced in response to disease and help the body fight against the particular disease. In this way, antibodies help the body develop an immunity to disease.

Anti-spike SARS-CoV-2 antibody titer trends over 15 months in healthcare workers in Boston

Researchers assessed the changes in the immunoglobulin titers against the receptor-binding domain of the spike protein of SARS-CoV-2 post-vaccination and natural SARS-CoV-2 infection in healthcare workers of Boston.

24 Mar 2022

Uptake of SARS-CoV-2 spike protein in human cerebrovascular cells

A recent study assessed the uptake of SARS-CoV-2 spike protein in human cerebrovascular cells via the lipid raft ganglioside.

24 Mar 2022

Study evaluates the prevalence of autoantibodies targeting type I interferons in critically-ill COVID-19 patients

Researchers assessed the prevalence of antibodies that neutralize the type I interferon antiviral activity and reactivate herpesviruses such as herpes simplex virus types 1 and 2 and/or cytomegalovirus infections in patients with critical COVID-19.

24 Mar 2022

Sino Biological and Ainnocence Partner to Offer Next-Generation Antibody Development CRO Services

Sino Biological is pleased to announce a CRO services partnership with Ainnocence, Inc. of San Jose, California.

From Sino Biological Inc. 24 Mar 2022

Powerful new Cytobank platform upgrade available from Beckman Coulter Life Sciences

Building on its legacy of providing labs with better solutions for analysis, management, and sharing of complex flow and mass cytometry data, Beckman Coulter Life Sciences announces a series of updates to its Cytobank platform.

From Beckman Coulter Life Sciences - Flow Cytometry 24 Mar 2022

T-cell and neutralizing antibody response after a third COVID-19 vaccine dose in hemodialysis patients

Researchers compare the impact of a third mRNA COVID-19 vaccine in hemodialysis patients by measuring antibody levels and IFN-γ responses.

23 Mar 2022

Researchers investigate Galectin-9 as a new treatment target for COVID-19

Researchers discuss alternate therapeutic targets for treating COVID-19 and the effects of Gal-9 on SARS-CoV-2 infection and the immune response.

23 Mar 2022

Study confirms no preexisting B-cell immunity against SARS-CoV-2 in pre-pandemic samples

A recent study finds that there is no considerable B-cell immunity against SARS-CoV-2 in unexposed healthy individuals.

23 Mar 2022

New nanoparticle-based COVID-19 vaccine platform could target other infectious diseases

Just one dose of a new nanoparticle-based COVID-19 vaccine was enough to produce an immune response in animals on track with vaccines currently in clinical use.

23 Mar 2022

Monoclonal antibodies found to prevent lung inflammation in SARS-CoV-2-Omicron-infected mice

Researchers investigated how monoclonal antibodies, S309 and AZD7442, reduced lung infection in mice infected with the SARS-CoV-2 new variant of concern Omicron's BA.1, BA.1.1, and BA.2 sublineages.

23 Mar 2022

Study discovers potent and selective human monoclonal antibodies against Omicron variant of SARS-CoV-2

In a new study, researchers discovered human monoclonal antibodies, which were specific and potent against the severe acute respiratory syndrome coronavirus 2 Omicron variant.

23 Mar 2022

Natural infection versus messenger RNA vaccination-induced immune protection

Researchers compared the immune protection provided by naturally acquired COVID-19 and its vaccination in Qatar residents.

23 Mar 2022

Novel monoclonal antibody found to have substantial neutralizing capacity against SARS-CoV-2 Omicron variant

Researchers reported a new monoclonal antibody, P2G3, which significantly neutralized the SARS-CoV-2 Omicron variant.

23 Mar 2022

Study investigates germinal center of antibody-mediated immunity against SARS-CoV-2

In a new study, researchers explored the germinal center of antibody-mediated immunity towards SARS-CoV-2.

23 Mar 2022

Detection of immune and clotting dysfunction in plasma and saliva after SARS-CoV-2 infection

It is becoming increasingly clear that individuals recovering from acute coronavirus disease (COVID-19) may develop post-acute sequelae (Post-Acute Coronavirus Syndrome, PACS).

23 Mar 2022

Novel nanoparticle-based COVID vaccines induce long-term neutralizing antibody response

Researchers report the results for a new SARS-CoV-2 vaccine currently in Phase III clinical trial known as I53-50.

22 Mar 2022

CD63-expressing extracellular vesicles neutralize SARS-CoV-2 variants of concern

Researchers evaluate antiviral effects of CD63 tetraspanin extracellular vesicles against SARS-CoV-2 and HIV-1.

22 Mar 2022

Rubella antibodies vs. COVID-19

A new study describes a potential relationship between antibody titers against the rubella virus and the severity of COVID-19.

22 Mar 2022

Lettuce could protect astronauts from bone density loss in microgravity

Astronauts might one day grow and eat genetically modified plants to ward off disease associated with long spaceflights. Researchers at the University of California, Davis College of Engineering have developed a transgenic, or genetically modified, lettuce producing a drug to protect against bone density loss in microgravity.

22 Mar 2022

Vaccine-induced antibody response to SARS-CoV-2 Omicron variant in patients with B cell malignancies with and without active B cell-targeted therapy

Researchers have determined the effect of booster immunization on the levels of antibodies generated, against SARS-CoV-2 variants, including the Omicron strain, in cancer patients with or without active B cell-targeted therapy.

22 Mar 2022

Antibody News and Research

Further Reading

Anti-spike SARS-CoV-2 antibody titer trends over 15 months in healthcare workers in Boston

Uptake of SARS-CoV-2 spike protein in human cerebrovascular cells

Study evaluates the prevalence of autoantibodies targeting type I interferons in critically-ill COVID-19 patients

Sino Biological and Ainnocence Partner to Offer Next-Generation Antibody Development CRO Services

Powerful new Cytobank platform upgrade available from Beckman Coulter Life Sciences

T-cell and neutralizing antibody response after a third COVID-19 vaccine dose in hemodialysis patients

Researchers investigate Galectin-9 as a new treatment target for COVID-19

Study confirms no preexisting B-cell immunity against SARS-CoV-2 in pre-pandemic samples

New nanoparticle-based COVID-19 vaccine platform could target other infectious diseases

Monoclonal antibodies found to prevent lung inflammation in SARS-CoV-2-Omicron-infected mice

Study discovers potent and selective human monoclonal antibodies against Omicron variant of SARS-CoV-2

Natural infection versus messenger RNA vaccination-induced immune protection

Novel monoclonal antibody found to have substantial neutralizing capacity against SARS-CoV-2 Omicron variant

Study investigates germinal center of antibody-mediated immunity against SARS-CoV-2

Detection of immune and clotting dysfunction in plasma and saliva after SARS-CoV-2 infection

Novel nanoparticle-based COVID vaccines induce long-term neutralizing antibody response

CD63-expressing extracellular vesicles neutralize SARS-CoV-2 variants of concern

Rubella antibodies vs. COVID-19

Lettuce could protect astronauts from bone density loss in microgravity

Vaccine-induced antibody response to SARS-CoV-2 Omicron variant in patients with B cell malignancies with and without active B cell-targeted therapy

Event guide: 5th Novel Conjugates Summit 2026 eBook

Latest eBooks

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Advancing degrader and proximity-based drug development

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo